The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age

• Auteurs principaux: Tianmeng Wen (Auteur), Xiaoqian Xu (Auteur), Chenghao Pan (Auteur), Shangying Hu (Auteur), Huan Zhao (Auteur), Xun Zhang (Auteur), Youlin Qiao (Auteur), Fanghui Zhao (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The quadrivalent human papillomavirus (qHPV) vaccine demonstrated high efficacy against vaccine-type-related precancers in Chinese females through a 6.6-year double-blind, randomized control trial (V501-041, NCT00834106). We present results for its long-term follow-up (LTFU) phase, evaluating vaccin...